SCHEMBL24425865

SCHEMBL24425865

C=CCC(CC=C)(C(=O)OCc1ccccc1)C(=O)OCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
PTPN1 P18031 3/20 0.48
PTPRC P08575 1/20 0.48
HCAR2 Q8TDS4 1/20 0.47
TDP1 Q9NUW8 2/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47
LMNA P02545 2/20 0.45
TSHR P16473 1/20 0.45
TGM2 P21980 1/20 0.43
HTT P42858 1/20 0.42
CA12 O43570 1/20 0.42
AKR1B10 O60218 1/20 0.42
AKR1B1 P15121 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24627654 0.91 ALDH1A1 (0.47) ALDH1A1PTPN1PTPRCHCAR2TDP1
SCHEMBL23657539 0.84 ALDH1A1 (0.46) ALDH1A1PTPN1PTPRCHCAR2TDP1
SCHEMBL29220153 0.84 ALDH1A1 (0.50) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL29220126 0.84 ALDH1A1 (0.50) ALDH1A1PTPN1PTPRCHCAR2TDP1
SCHEMBL1273767 0.84 ALDH1A1 (0.50) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL19388495 0.83 ALDH1A1 (0.49) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL20150647 0.83 ALDH1A1 (0.49) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL15114507 0.83 ALDH1A1 (0.49) ALDH1A1HCAR2TDP1MAPK1L3MBTL1
SCHEMBL8688641 0.81 SMN1; SMN2 (0.47) ALDH1A1PTPN1PTPRCHCAR2TDP1
SCHEMBL14847458 0.81 ALDH1A1 (0.47) ALDH1A1HCAR2TDP1MAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116813471-A Trifluoromethyl alkynylation reaction of photocatalytic 1, 6-diene and application 郑州大学 2023-09-29 CN disclosed
US-20220219155-A1 Compositions And Methods For Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2022-07-14 US disclosed
US-11331656-B2 Compositions and methods for visible-light-controlled ruthenium-catalyzed olefin metathesis THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2022-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11331656-B2 Compositions and methods for visible-light-controlled ruthenium-catalyzed olefin metathesis PPOX, CYBA, CYBB ALDH1A1 1395/4885PTPN1 4647/4885PTPRC 3769/4885
US-20220219155-A1 Compositions And Methods For Visible-Light-Controlled Ruthenium-Catalyzed Olefin Metathesis PPOX, CYBA, CYBB ALDH1A1 1395/4885PTPN1 4647/4885PTPRC 3769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.